Opioid Settlement
The Office of Drug Prevention, Treatment, and Enforcement, in partnership with the Indiana Family and Social Services Administration - Division of Mental Health and Addiction and the Indiana Department of Health, has developed a framework for how the State of Indiana plans to use the state's 35% appropriation for abatement from the National Opioid Settlement with distributors McKesson, Cardinal Health and AmerisourceBergen and manufacturer Janssen Pharmaceuticals, Inc. and its parent company Johnson & Johnson. House Enrolled Act 1193, passed by the Indiana General Assembly and signed by Governor Eric J. Holcomb in March 2022, creates a 50/50 state and local split and defines the intensity metrics on how much money each locality will receive.
The State is using the Johns Hopkins Bloomberg School of Public Health's five guiding principles to ensure dollars are used most effectively:
- Spend the money to save lives
- Use evidence to guide spending
- Invest in youth prevention
- Focus on racial equity
- Develop a fair and transparent process for deciding where to spend the funds.
Documents
- Click here to view Indiana's plan for the 35% appropriated for abatement to the Indiana Family and Social Services Administration.
- Exhibit E of the national settlement document outlines the approved abatement uses.
- Click here to view distribution totals for participating subdivisions.
Indiana's Matching Program
As part of the National Opioid Settlement, the Indiana Family and Social Services Administration – Division of Mental Health and Addiction (DMHA) in partnership with the Office of Governor Eric J. Holcomb is making available a one-time funding opportunity to local units of government to support evidence-based prevention, treatment, recovery, harm reduction, behavioral health workforce, enforcement, jail treatment, recovery residences, and other services and initiatives across the state. This RFF requests responses from local units of government that received funds per the National Opioid Settlement Agreement or any entity that has been granted funds from a qualified local unit of government. Eligible local units of government and approved abatement uses outlined by the National Opioid Settlement Agreement are linked above.
Respondents must provide match funds. Match funds may come from any source, including local distributions from the National Opioid Settlement, Federal American Rescue Plan (ARP) funds, local general funds, private contributions, or philanthropy dollars. Use of state-issued grants (i.e., Community Catalyst, Accelerator, Community Coordination, etc.) is not permitted for match funds. Priority will be given to local units of government that pool together funds and regionalize efforts.
The total funding amount available for this RFF is $25,000,000. State awards may be greater than or less than the respondent’s request amount or match amount. Final proposals will be judged on totality of responses. This grant will be funded beginning July 1, 2023, through June 30, 2025.
Additional details and how to apply is available here. A question-and-answer document is available here.
Frequently Asked Questions
How much money should my community expect to receive?
The Indiana Office of the Attorney General calculates the amounts local units of governments are to receive from the settlement per the terms and conditions of the settlement and House Enrolled Act 1193. The OAG will provide the amounts to the State Budget Agency, which then is responsible for determining and calculating any attorney fees that must be paid from a local unit of government allocation prior to distribution. Click here to view distribution totals for participating subdivisions.
How do I know if my community expects to receive funding?
Over 640 Indiana towns, cities, and counties have opted into the state’s settlement with distributors McKesson, Cardinal Health, and AmerisourceBergen and manufacturer Janssen Pharmaceuticals, Inc., and its parent company Johnson & Johnson. Click here to view distribution totals for participating subdivisions.
How will funds be distributed?
House Enrolled Act 1193, passed by the Indiana General Assembly and signed by Governor Eric J. Holcomb in March 2022, creates a 50/50 state and local split and defines the intensity metrics on how much money each locality will receive. Local subdivisions received their first payments in December 2022. The State Budget Committee approved Indiana's plan for the 35% appropriated for abatement to the Indiana Family and Social Services Administration in December 2022. Funding announcements can be found here.
When should Indiana expect to receive funds?
Local subdivisions received their first payments in December 2022.
How are funds being spent?
Exhibit E of the national settlement document outlines the approved abatement uses. Indiana's plan for the 35% appropriated for abatement to the Indiana Family and Social Services Administration can be found here.
Who is the point of contact?
House Enrolled Act 1193 defines the responsibilities of involved state agencies. For questions regarding the use of Indiana's 35% appropriation for abatement, contact the Office of Drug Prevention, Treatment and Enforcement at drugpte@gov.in.gov.
What are the requirements for reporting how funds are spent?
At this time, information on reporting requirements has not been made available by the national settlement administrator.
How will Indiana be transparent?
The Office of the Governor has created a webpage at in.gov/recovery/settlement where updates will be regularly posted.
Additional Resources
- National Opioid Settlement
- Office of the Attorney General - Complex Litigation
- Division of Mental Health and Addiction - Funding Announcements
Contact Us
Questions? Contact us at drugpte@gov.in.gov.
